We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close
2 FREE PAGES remain this month
or
for more website access

You can view 2 more articles. Please register to view this article, or subscribe for share tips and full online access.

Fireworks at Renishaw

Record half-year sales and a much improved outlook triggered a rush back into Renishaw . The shares, which lost over half their value in just a few months last year, shot up 20 per cent at one stage to their highest in almost five months. Investment in production systems within automotive, civil aviation, agriculture and energy markets "looks increasingly favourable", said management at the precision engineer, and recovery in the key electronics sector is on the cards.

That's just what investors wanted to hear, guaranteeing that they overlooked a jump in headcount and infrastructure spend that trimmed operating profit 14 per cent to £29.7m. It also helped soothe news that the Far East sales fell 9 per cent to £49.6m as Chinese sales - its largest market last year - slumped 25 per cent, largely reflecting weak demand for encoders from one electronics firm there, first flagged in October. It has since told assistant chief executive Ben Taylor that it's "just a pause"; likely to last at least three months.

European sales grew 25 per cent to £55.8m, propelled by automotive production and the civil aerospace boom. In the Americas they grew 23 per cent to £36.5m, driving revenue at the core metrology division up 10 per cent to £135.9m. Last year's acquisition of Measurement Devices and MTT helped, too. But rising costs left profits there down 8 per cent at £35.7m. Renishaw promises to keep an eye on outgoings, but still spent nearly £18m on property and equipment - more than it did in the last full year - as it gears up for recovery.

And operating losses at the smaller healthcare division grew to £6m from £4.2m, despite a 27 per cent hike in revenue. Still, rising sales of neurosurgical robots and increasing contribution from diagnostics should drive "significant improvement" during the second half.

Broker Numis Securities forecasts adjusted pre-tax profit of £75.8m in 2012 and adjusted EPS of 83.3p (£80.4m and 88p in 2011).

RENISHAW (RSW)
ORD PRICE:1,315pMARKET VALUE:£957m
TOUCH:1,307-1,315p12-MONTH HIGH:1,886pLow: 800p
DIVIDEND YIELD:2.7%PE RATIO:15
NET ASSET VALUE:284p*NET CASH:£26.6m

Half-year to 31 DecTurnover (£m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
201013235.239.010.3
201114731.234.710.3
% change+11-11-11-

Ex-div: 7 Mar

Payment: 10 Apr

*Includes intangible assets of £49m, or 68p a share

IC VIEW:

These results largely matched revised forecasts, but the bullish tone of the outlook statement is key here. Still, visibility is just one month and forecasts for global growth are poor. The shares, meanwhile, are up over 60 per cent since November and trade on 16 times forecast earnings - leaving them up with events for now. Hold.

Last IC view: Fairly priced, 915p, 21 October 2011

visible-status-Standard story-url-Renishaw_Results_250112.xml

By Lee Wild,
25 January 2012

Print this article

Related Companies

Register today and get...

Register today and get...